***************************************
E-DRUG R&D Report Availability
Stephen Dockerill asks many interesting questions about R&D
in the pharmaceutical industry. I would also like to know
the answers to these. Will his company make their
(usually extravagantly priced) report available free via
the e-drug network?
----------------------
Tom Walley
twalley@liv.ac.uk
[This raises an interesting issue. It is not just expensive company reports
which do not become available. I am often surprised at the number of
reports available in developed countries which are not easily available in
the countries themselves about which the report is produced. I think there
is a responsibility on consultants and academics to ensure that the reports
they produce are made available to people in the country studied. Richard
Laing E-Drug Moderator for May]
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
|